Method for adjusting body fat deposition, meat quality and cold resistance of pigs

By injecting pigs with 5-(tetradecyloxy)-2-furoic acid (TOFA), the acetyl-CoA carboxylase is inhibited and browned fat cells is induced, and the problem of improving pork quality and cold resistance is solved, and the problem of improving pork quality and cold resistance is achieved. There was a significant reduction in fat and increased lean meat rate.

CN118924733AInactive Publication Date: 2024-11-12INSTITUTE OF ANIMAL SCIENCES OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411413923.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-11
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In modern animal husbandry, how to improve the quality of pork, reduce fat deposition, improve pigs' cold resistance, and meet the needs of the market and consumers is a core goal, but the existing technology is difficult to effectively achieve.

Method used

By injecting pigs with 5-(tetradecyloxy)-2-furoic acid (TOFA), it is used to inhibit the activity of acetyl-CoA carboxylase, induce the production of browned fat cells, and improve the pig's cold resistance and lean meat. and reduce fat deposition.

Benefits of technology

TOFA significantly improves the pig's temperature regulation ability, reduces fat deposition, improves lean meat rate and meat quality, and provides significant economic trait improvement effect without affecting pig growth performance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924733A_ABST
    Figure CN118924733A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of biotechnology and animal husbandry, and provides a method for adjusting body fat deposition, meat quality and cold resistance of pigs. According to the present invention, the TOF (5-(Tetradecyl)-2-furoic acid, 5-(tetradecyl oxygen)-2-furoic acid) is adopted to treat the pig, such that the body temperature regulation ability of the pig is significantly improved, the fat deposition is reduced, and the lean meat percentage and the meat quality are improved. The TOFA serving as an acetyl-coenzyme A carboxylase allosteric inhibitor not only can induce the generation of browning fat cells and improve the endurance capacity of pigs in a cold environment, but also can improve the meat quality while the lean meat percentage of the pigs is high. The method is simple and convenient to operate and remarkable in effect, provides a new means for improving important economic traits of pigs, and has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology and animal husbandry, and in particular relates to a method for regulating pig body fat deposition, meat quality and cold resistance. Background Art

[0002] In modern animal husbandry, the yield and quality of pork have an important impact on the economic benefits of the industry. Pork is one of the most consumed sources of animal protein in the world. Pork yield is mainly affected by fat deposition, and pork quality is affected by intramuscular fat content. In addition, adipose tissue is the main organ for adaptive heat production. Under cold stimulation, white fat in pigs can be converted into beige fat cells with heat-producing function. The generation of beige fat cells can not only improve the tolerance of animals in cold environments, but also has the potential to reduce body fat storage and increase lean meat rate. How to improve the quality of pork, reduce fat deposition, improve cold resistance, and meet the needs of the market and consumers is one of the core goals of the animal husbandry industry. Summary of the invention

[0003] The purpose of the invention is to provide a method for regulating pig body fat deposition, meat quality and cold resistance.

[0004] In order to achieve the purpose of the present invention, in a first aspect, the present invention provides any of the following uses of 5-(tetradecyloxy)-2-furoic acid (TOFA): (1) Used to improve pigs' cold resistance and body temperature regulation ability; (2) Used to reduce pig fat deposition; (3) Used to increase lean meat rate and improve pork quality; (4) Used to induce the formation of browning adipocytes in pigs.

[0005] In a second aspect, the present invention provides a method for improving the cold resistance and body temperature regulation ability of pigs, comprising intraperitoneal injection or intravenous injection (such as ear vein injection) of an appropriate amount of 5-(tetradecyloxy)-2-furoic acid into the pigs.

[0006] In a third aspect, the present invention provides a method for reducing pig fat deposition, comprising injecting an appropriate amount of 5-(tetradecyloxy)-2-furoic acid into the pig intraperitoneally or intravenously (such as ear vein injection).

[0007] In a fourth aspect, the present invention provides a method for increasing lean meat rate and improving pork quality, the method comprising intraperitoneally or intravenously (such as intraauricular vein injection) injecting an appropriate amount of 5-(tetradecyloxy)-2-furoic acid into a pig.

[0008] In a fifth aspect, the present invention provides a method for inducing the formation of browning fat cells in pigs, the method comprising intraperitoneally or intravenously (such as intraauricular vein injection) injecting an appropriate amount of 5-(tetradecyloxy)-2-furoic acid into the pig.

[0009] In the aforementioned method, the injection amount of 5-(tetradecyloxy)-2-furoic acid is 0.5-1.5 mg / kg (preferably 1 mg / kg) body weight (such as intraperitoneal injection or ear vein injection).

[0010] In the present invention, the pig includes but is not limited to Bama pig.

[0011] By means of the above technical solution, the present invention has at least the following advantages and beneficial effects: The present invention significantly improves the body temperature regulation ability of pigs by treating them with TOFA, reduces fat deposition, and improves lean meat rate and meat quality. As an inhibitor of acetyl-CoA carboxylase (ACACA), TOFA can not only induce the formation of browning fat cells and improve the tolerance of pigs in cold environments, but also improve meat quality without significantly affecting the growth performance of pigs. The method is simple to operate and has significant effects. It provides a new means for improving important economic traits of pigs and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 In the preferred embodiment of the present invention, TOFA induces the formation of beige adipocytes and enhances the cold tolerance of piglets. (A) Infrared imaging of body temperature of Bama pigs treated with TOFA at room temperature (RT) and 4°C cold stimulation for 4 hours; (BD) Rectal temperature of Bama pigs treated with TOFA at room temperature (RT) and 4°C cold stimulation for 4 hours (n=5); (CD) Maximum temperature of the abdomen and chest surface of Bama pigs treated with TOFA at room temperature (RT) and 4°C cold stimulation for 4 hours (n=5); (E) HE staining results of subcutaneous fat (SAT), back fat and perirenal fat of Bama pigs in TOFA treatment group and vehicle control group after 4°C cold stimulation for 4 hours; (F) mRNA levels of beige adipocyte marker genes in subcutaneous fat (SAT) of Bama pigs treated with TOFA and vehicle control group after 4°C cold stimulation for 4 hours (n=5); (GH) Protein levels of beige adipocyte marker genes in subcutaneous fat (SAT) of Bama pigs treated with TOFA and vehicle control group after 4°C cold stimulation for 4 hours.

[0013] Figure 2In the preferred embodiment of the present invention, TOFA treatment significantly reduced fat deposition and increased intramuscular fat content in Bama pigs. (A) Weekly changes in body weight of Bama pigs treated with TOFA or vehicle for 5 weeks (n=7-8); (BH) Comparison of feed intake, feed conversion rate, eye muscle area, average backfat thickness, body fat percentage, lean meat rate and intramuscular fat content of Bama pigs after 5 weeks of TOFA or vehicle treatment (n=7-8); (I) Photos of eye muscles of Bama pigs after slaughter after 5 weeks of TOFA or vehicle treatment; (J) HE staining results of subcutaneous fat (SAT), back fat and mesenteric fat of Bama pigs after 5 weeks of TOFA or vehicle treatment; (K) mRNA levels of beige adipocyte marker genes in subcutaneous fat (SAT) of Bama pigs after 5 weeks of TOFA or vehicle treatment (n=7-8); (LM) Protein levels of thermogenic and lipolysis genes in subcutaneous fat (SAT) of Bama pigs after 5 weeks of TOFA or vehicle treatment (n=3).

[0014] In the figure, P<0.05 , P<0.01, P<0.001. DETAILED DESCRIPTION

[0015] 5-(Tetradecyloxy)-2-furoic acid (TOFA) can inhibit the activity of acetyl-CoA carboxylase (ACACA, Gene ID of the enzyme in NCBI: 397324), thereby inhibiting the de novo synthesis of fatty acids. Studies have shown that the inhibition of de novo fatty acid synthesis significantly enhances the formation of beige fat under cold stimulation, suggesting that it may have important application potential in the regulation of body temperature and fat deposition. So far, there have been no reports on the research of TOFA in the regulation of body temperature, fat deposition and meat quality of pigs.

[0016] The present invention provides a method for treating pigs with TOFA, which improves the body temperature regulation ability by inducing beige fat production, reduces fat deposition and improves meat quality, and provides a new technical approach for improving pork quality and production performance.

[0017] The present invention adopts the following technical solution: 1. Methods to improve pigs' ability to regulate body temperature The present invention provides a method for improving the thermoregulation ability of pigs by TOFA treatment. Specifically, 5-week-old Bama piglets were selected as experimental subjects and randomly divided into a control group and a treatment group. The treatment group was injected with 1 mg / kg of TOFA (Selleck, S6690) through the ear vein. Each pig was injected with 1 ml of working solution per kilogram of body weight. The preparation method for a 5 kg pig was as follows: 5 mg TOFA was dissolved in 250 μL DMSO (the mother solution concentration was 20 mg / mL), 250 μL of the mother solution was added to 2000 μL PEG400, 250 μL Tween 80 was added after mixing, and 2500 μL ddH2O was added, mixed to form a working solution, and used immediately. The control group was injected with an equal amount of carrier solution (a mixture of DMSO, PEG400, Tween 80 and ddH2O). One hour after the injection, the rectal temperature of all piglets was measured, and the initial body surface temperature was photographed using an infrared thermal imager. Subsequently, the piglets were exposed to a cold environment at 4°C for 4 hours, and the rectal temperature was measured again and infrared thermal imaging images were taken. The results showed that pigs in the TOFA-treated group showed significantly higher surface temperatures of the abdomen, chest and back, as well as rectal temperatures after cold exposure. Histological analysis showed that TOFA treatment significantly increased the number of brown adipocytes in perirenal fat and upregulated the expression levels of beige adipocyte marker genes (such as PRDM16, EBF2, DIO2 and UCP3) and related proteins.

[0018] 2. Methods to reduce fat deposition and increase intramuscular fat content The present invention also provides a method for reducing fat deposition in pigs and increasing lean meat rate by long-term TOFA treatment. Specifically, 10-week-old Bama pigs were selected as experimental subjects and randomly divided into two groups (8 in each group). After a one-week adaptation period, the formal experiment began. The pigs in the treatment group were intraperitoneally injected with 1 mg / kg TOFA every day. Each pig was injected with 1 ml of working solution per kilogram of body weight. The preparation method for a 5 kg pig was as follows: 5 mg TOFA was dissolved in 250 μL DMSO (the mother solution concentration was 20 mg / mL), 250 μL of the mother solution was added to 2000 μL PEG400, 250 μL Tween 80 was added after mixing, and 2500 μL ddH2O was added. The working solution was mixed and used immediately. The control group was injected with an equal amount of carrier solution (a mixture of DMSO, PEG400, Tween 80 and ddH2O), and the experiment lasted for five weeks. During the entire experimental period, the feed intake and body weight of each pig were recorded. After the experiment, the slaughter performance indicators of each group of pigs were evaluated, including carcass lean meat percentage, body fat percentage, eye muscle area and average backfat thickness. The results showed that the average backfat thickness and body fat percentage of the TOFA-treated group were significantly lower than those of the control group, while the lean meat percentage was significantly increased and the intramuscular fat (IMF) content was also increased. In addition, immunohistochemistry and immunoblotting analysis showed that the expression levels of browning adipocyte marker genes, such as PRDM16 (Gene ID: 100624476), DIO2 (Gene ID: 414379), PGC1α (Gene ID: 397013), EBF2 (Gene ID: 100155094) and CIDEA (Gene ID: 100127171), and their related proteins were significantly upregulated in the TOFA-treated group.

[0019] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.

[0020] TOFA used in the following examples was purchased from Selleck.

[0021] The molecular structure of TOFA is as follows:

[0022] Example 1 TOFA treatment improves the thermoregulatory ability of Bama pigs Objective: This study aimed to evaluate whether 5-tetradecanoyl-2-furancarboxylic acid (TOFA) treatment could enhance the thermoregulatory ability of Bama piglets by inducing the generation of beige adipocytes.

[0023] Experimental methods: 1. Experimental design: Ten healthy five-week-old Bama boars with similar body weight were randomly divided into two groups (5 in each group). The control group was injected with the vehicle solution DMSO through the ear vein, while the TOFA group was injected with 1 mg / kg TOFA (Selleck, S6690). One hour after injection, the rectal temperature of the piglets was measured, and infrared images of the initial body temperature were taken. Subsequently, the piglets were placed in a 4°C environment for 4 hours of acute cold stimulation, and the rectal temperature was measured again and infrared images were taken.

[0024] 2. Infrared thermal imaging analysis: Use an infrared thermal imaging camera to capture the body surface temperature after 0 and 4 hours of cold exposure. Use image analysis software to calculate the average maximum surface temperature of the abdomen, chest, and back.

[0025] 3. qPCR analysis: Total RNA was extracted from adipose tissue of Bama piglets (TRIzol reagent, Thermo Fisher Scientific, 15596018) and purified according to the manufacturer's instructions. 1 μg of total RNA was reverse transcribed into cDNA (PrimeScript™ RT kit, Takara, RR047A), and quantitative PCR analysis was performed on the QuantStudio 3 Real-Time PCR System (Life Technologies) using TB Green Premix Ex Taq (Takara, RR420A) to analyze beige adipocyte marker genes PRDM16, EBF2, DIO2, UCP3 and CIDEA, with 18S rRNA (Gene ID: 100861538) as the internal reference gene for normalization. The primer sequences are shown in Table 1 (SEQ ID NO: 1-14).

[0026] Table 1 Primer sequences for fluorescence quantitative PCR

[0027] 4. Immunoblot analysis: Cell lysates (100 μL each) were extracted using M-PERTM mammalian protein extraction reagent (Thermo Fisher Scientific, 78503) and supplemented with a protease inhibitor cocktail (Roche, 04693159001). After centrifugation (12,000 × g, 4°C, 20 min), the obtained proteins (20-50 μg) were separated by 10% SDS-polyacrylamide gel electrophoresis and transferred to a PVDF membrane (Merck-Millipore, IPVH00010). Primary antibodies (such as PRDM16 and HSL) were used for detection, and the immunoreactive bands were visualized using the FluorChem M fluorescence imaging system (Tanon, 5200) and ECL developer (Tanon, 180–501).

[0028] 5. Histological analysis: Adipose tissue samples of the treated piglets were collected and fixed with 10% neutral buffered formalin for 24 h. The samples were dehydrated by gradient, cleared with xylene and embedded in paraffin. The sections were sliced ​​at a thickness of 5 μm and stained with a hematoxylin-eosin (H&E) staining kit (Beyotime, C0105).

[0029] Experimental results: Infrared thermal imaging results showed that after 4 hours of cold exposure, the surface temperatures of the abdomen, chest and back of the TOFA-treated group were significantly higher than those of the control group ( Figure 1 A).

[0030] The rectal temperature of the piglets in the TOFA treatment group after cold exposure was also significantly higher than that in the control group, while there was no significant difference in rectal temperature between the two groups at room temperature ( Figure 1 B).

[0031] The average maximum surface temperature of the abdomen and chest regions was calculated, and the results showed that the TOFA-treated group maintained a higher body surface temperature during cold exposure ( Figure 1 , C and D).

[0032] H&E staining results showed that the control group's adipose tissue mainly contained unilocular adipocytes, while the TOFA-treated group, especially the perirenal fat, significantly increased the number of beige adipocytes ( Figure 1 E).

[0033] Beige adipocyte marker genes in subcutaneous adipose tissue of TOFA-treated group PRDM16 , EBF2 , DIO2 and UCP3 The RNA expression level of Figure 1 F), the corresponding PRDM16 and HSL protein levels also increased significantly ( Figure 1, G and H).

[0034] Conclusion: TOFA treatment can significantly induce the formation of beige adipocytes in Bama piglets and improve their thermoregulatory ability under cold exposure conditions.

[0035] Example 2 Long-term TOFA treatment significantly reduces fat deposition and increases lean meat rate in Bama pigs Purpose: This example aims to evaluate the effect of long-term (five weeks) TOFA treatment on fat deposition and lean meat percentage in 10-week-old Bama pigs.

[0036] Experimental methods: 1. Experimental design: 16 ten-week-old Bama pigs were randomly divided into two groups (8 in each group) and allowed to eat and drink freely in a constant temperature environment of 25 ± 2°C. After a one-week adaptation period, the formal experiment began, and DMSO (control group) or 1 mg / kg TOFA (TOFA group) was intraperitoneally injected every day for 5 weeks. During the experiment, the feed intake and body weight of each pig were carefully recorded.

[0037] 2. Slaughter performance evaluation: At 16 weeks of age, all pigs were slaughtered and samples were collected immediately. Slaughter performance indicators, including body weight, feed intake, feed conversion rate, carcass lean meat rate, carcass fat percentage, eye muscle area and average backfat thickness, were measured. The intramuscular fat content (IMF) was determined by petroleum ether extraction using a Soxhlet apparatus. The results showed that the average backfat thickness and body fat percentage of pigs in the TOFA-treated group were significantly reduced, while the lean meat rate was significantly increased. The IMF content was significantly increased, indicating that the meat quality was improved.

[0038] 3. Immunohistochemistry and histological analysis: Adipose tissue sections were fixed with 10% neutral buffered formalin, embedded in paraffin and sliced ​​(5 μm), and immunohistochemical analysis was performed using a DAB colorimetric kit (Solarbio, DA1010) and anti-tyrosine hydroxylase antibody (Abcam, ab137869). The staining results showed that the proportion of multilocular adipocytes in adipose tissue of the TOFA-treated group increased significantly. Through histological observation, multilocular adipocytes were distributed in multiple fat deposition areas.

[0039] 4. Biochemical and gene expression analysis: Immunoblotting was used to detect browning marker genes in SAT of the TOFA-treated group ( PRDM16 , DIO2 , PGC1α , EBF2 and CIDEA The expression levels of PRDM16 and related proteins (such as PRDM16, PGC1α, pHSL, and DIO2) were normalized using 18S rRNA as the internal reference gene. The primer sequences are shown in Table 1.

[0040] Experimental results: There were no significant differences in body weight, feed intake, feed conversion rate and eye muscle area between the TOFA-treated group and the control group ( Figure 2 , AD).

[0041] TOFA treatment significantly reduced backfat thickness and body fat percentage, while increasing lean meat percentage ( Figure 2 , EG).

[0042] The intramuscular fat content of the experimental group was significantly higher than that of the control group ( Figure 2 H).

[0043] Photos of Bama pig eye muscles after being treated with TOFA or vehicle solution for 5 weeks are shown in Figure 2 I.

[0044] H&E staining showed that there were a certain number of multilocular adipocytes in various fat deposition sites in the TOFA-treated group ( Figure 2 J).

[0045] Gene expression analysis showed that TOFA significantly upregulated the expression levels of beige adipocyte marker genes in subcutaneous adipose tissue ( Figure 2 K), and the corresponding PRDM16, PGC1a, pHSL and DIO2 protein levels were also significantly increased ( Figure 2 , L and M).

[0046] Conclusion: ACACA inhibitor TOFA significantly improved the lean meat percentage and reduced fat deposition in Bama pigs, and has important potential for application in pig production.

[0047] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.

Claims

1. Any of the following applications of TOFA: (1) Used to improve pigs' cold resistance and body temperature regulation ability; (2) Used to reduce pig fat deposition; (3) Used to increase lean meat rate and improve pork quality; (4) Used to induce the formation of brown adipocytes in pigs; TOFA is 5-(tetradecyloxy)-2-furoic acid.

2. A method for improving pigs' cold resistance and body temperature regulation ability, It is characterized in that The method comprises injecting a proper amount of 5-(tetradecyloxy)-2-furoic acid into pigs intraperitoneally or intravenously.

3. A method for reducing pig fat deposition, It is characterized in that The method comprises injecting a proper amount of 5-(tetradecyloxy)-2-furoic acid into pigs intraperitoneally or intravenously.

4. A method for increasing lean meat rate and improving pork quality, It is characterized in that The method comprises injecting a proper amount of 5-(tetradecyloxy)-2-furoic acid into pigs intraperitoneally or intravenously.

5. A method for inducing the formation of browning fat cells in pigs, It is characterized in that The method comprises injecting a proper amount of 5-(tetradecyloxy)-2-furoic acid into pigs intraperitoneally or intravenously.

6. The method according to any one of claims 2 to 5, It is characterized in that The injection amount of 5-(tetradecyloxy)-2-furoic acid is 0.5-1.5 mg / kg body weight.

7. The method according to claim 6, It is characterized in that The injection amount of 5-(tetradecyloxy)-2-furoic acid was 1 mg / kg body weight.

8. The method according to any one of claims 2 to 7, It is characterized in that The pig is a Bama pig.

Citation Information

Patent Citations

  • Application of hyodeoxycholic acid in reduction of animal fat deposition

    CN115813936A